期刊文献+

全部胚胎冷冻保存在卵巢低反应患者治疗中的应用

Application of All Embryos Cryopreservation in the Treatment of Patients With Low Ovarian Response
下载PDF
导出
摘要 目的探讨全部胚胎冷冻保存在卵巢低反应患者治疗中的效果。方法选择2015年9月~2016年5月在我院诊治的卵巢低反应患者40例,对照组采用新鲜胚胎移植,观察组采用全部胚胎冷冻保存移植,观察两组预后情况。结果观察组与对照组的临床妊娠率分别为60.0%和55.0%,两组对比差异无统计学意义,P〉0.05。对照组出现迟发性卵巢过度刺激综合征3例,观察组出现迟发性卵巢过度刺激综合征1例。结论全部胚胎冷冻保存在卵巢低反应治疗中不影响妊娠结局,是预防迟发性卵巢过度刺激综合征发生的一种理想方法。 Objective To investigate the application of all embryos cryopreservation in the treatment of patients with low ovarian response. Methods 40 cases of patients with low ovarian response in our hospital from September 2015 to May 2016 were selected,the control group used fresh embryo transfer,the observation group used all embryos cryopreservation,the prognosis of the two groups were observed. Results The clinical pregnancy rate of the observation group and the control group were 60% and 55% respectively,there was no significant difference between the two groups(P〉 0.05). In the control group,there were 3 cases of delayed ovarian syndrome,while 1 case in observation group. Conclusion Application of all embryos cryopreservation in the treatment of patients with low ovarian response do not affect the outcome of pregnancy,it is an ideal method to prevent the occurrence of delayed ovarian hyper stimulation syndrome.
作者 潘晖
出处 《中国卫生标准管理》 2016年第19期67-68,共2页 China Health Standard Management
关键词 新鲜胚胎移植 全部胚胎冷冻保存 卵巢低反应 Fresh embryo transfer All embryos cryopreservation Low ovarian response
  • 相关文献

参考文献6

二级参考文献73

  • 1陈锋,朱依敏,孙赛君,许小萍.胚胎冷冻时间对冻融胚胎移植结局的影响[J].浙江医学教育,2010,9(3):36-38. 被引量:5
  • 2朱伟杰,李菁.冷冻保存对人类卵子结构与功能的影响[J].生殖与避孕,2005,25(7):418-420. 被引量:5
  • 3Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril, 2010, 94(2):389-400.
  • 4Kashyap S, Parker K, Cedars MI, et al. Ovarian hyperstimu- lation syndrome prevention strategies: reducing the human chorionic gonadotropin trigger dose. Sem in Reprod Med, 2010, 28(6):475-85.
  • 5Nargund G. Low-dose hCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles. Reprod Biomed Online, 2007, 14(6):682-5.
  • 6Schmidt DW, Maler DB, Nulsen JC, et al. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization. Fertil Steril, 2004, 82(4):841-6.
  • 7Aboulghar M. Prediction of ovarian hyperstimulation syn- drome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod, 2003, 18(6):1140-1.
  • 8Cummins JM, Breen TM, Harrison KL, et al. Aformula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J in Vitro Fertil Embryo Transfer, 1986, 3(5):284-95.
  • 9Gomez R, Soares SR, Busso C, et al. Physiology and pathology of ovarian hyperstimulation syndrome. Sem Reprod Med, 2010, 28(6):448-57.
  • 10The European Recombinant LH Study Group. Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final folli- cular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab, 2001, 86(6):2607-18.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部